ACB Share Price Performance
CA$0
-6.58 (-100.00%)
Price CA$0
Fair ValueCA$8.00
Share Pricen/a
Aurora Cannabis Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 68 Fair Values set on narratives written by author
ACB Community Narratives
AN
Fair Value
·Fair Value CA$8 32.9% undervalued intrinsic discount
Global Cannabis Legalization And Medical Integration Will Expand Wellness Markets
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value CA$4 34.3% overvalued intrinsic discount
European Cannabis Regulations And Intense Competition Will Hamper Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value CA$6.14 12.5% undervalued intrinsic discount
European And Australian Medical Cannabis Markets Will Unlock Enduring Potential
0users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
European Cannabis Regulations And Intense Competition Will Hamper Expansion
Aurora Cannabis is pushing deeper into international medical markets, but shifting rules in Europe and tougher competition could slow growth and squeeze profits. See why rising costs and the pace of medical adoption may matter as much as new country launches.Read more
AN
CA$4
34.3% overvalued intrinsic discount
Fair Value
Profit Margin
8.5%
Future PE
11.46x
Price in 2029
CA$4.41
Global Cannabis Legalization And Medical Integration Will Expand Wellness Markets
Aurora Cannabis is set up to benefit if more countries treat cannabis like a normal part of healthcare, thanks to its track record navigating tough rules and building medical-market relationships. But shifting regulations, new rivals, and weak brand pull could quickly squeeze profits and stall the growth story.Read more
AN
CA$8
32.9% undervalued intrinsic discount
Fair Value
Profit Margin
4.4%
Future PE
44.47x
Price in 2029
CA$8.82
European And Australian Medical Cannabis Markets Will Unlock Enduring Potential
Aurora Cannabis leans into medical cannabis sales in Europe and Australia, betting that tighter rules and growing acceptance help established players win share and improve profitability. The upside looks tied to staying ahead on compliance and keeping costs in check as competition, regulation shifts, and weaker side businesses could pressure results.Read more
AN
CA$6.14
12.5% undervalued intrinsic discount
Fair Value
Profit Margin
5.12%
Future PE
29.65x
Price in 2029
CA$6.77
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
ACB: Medical Refocus And Impairment Charges Will Shape Balanced Outlook
Fair Value: CA$4 34.3% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ACB: Medical Focus And Rescheduling Tailwinds Will Drive Future Upside Potential
Fair Value: CA$8 32.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ACB: Favorable Rescheduling Outlook Will Support Shift To Global Medical Focus
Fair Value: CA$6.14 12.5% undervalued intrinsic discount
35 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Aurora Cannabis Inc. Key Details
About ACB
- Founded
- 2013
- Employees
- 1028
- CEO
- WebsiteView website
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty’s, Whistler, and WMMC. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
